PT99690A - Metodo para o tratamento de doencas utilizando derivados de 2'-o-alquil-adenosina e para a preparacao de composicoes que os contem e de um hidrato de 6-ciclo- -hexil-2'-ometil-adenosina - Google Patents
Metodo para o tratamento de doencas utilizando derivados de 2'-o-alquil-adenosina e para a preparacao de composicoes que os contem e de um hidrato de 6-ciclo- -hexil-2'-ometil-adenosinaInfo
- Publication number
- PT99690A PT99690A PT99690A PT9969091A PT99690A PT 99690 A PT99690 A PT 99690A PT 99690 A PT99690 A PT 99690A PT 9969091 A PT9969091 A PT 9969091A PT 99690 A PT99690 A PT 99690A
- Authority
- PT
- Portugal
- Prior art keywords
- adenosine
- alkyl
- treatment
- ometel
- cyclohexyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4039060A DE4039060A1 (de) | 1990-12-07 | 1990-12-07 | Neue kristallform |
GB919116212A GB9116212D0 (en) | 1991-07-26 | 1991-07-26 | New use of organic compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
PT99690A true PT99690A (pt) | 1992-10-30 |
PT99690B PT99690B (pt) | 1999-05-31 |
Family
ID=25899101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT99690A PT99690B (pt) | 1990-12-07 | 1991-12-05 | Metodo para o tratamento de doencas utilizando derivados de 2'-o-alquil-adenosina e para a preparacao de composicoes que os contem e de um hidrato de 6-ciclo- -hexil-2'-ometil-adenosina |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP0490818B1 (pt) |
JP (2) | JPH04290895A (pt) |
AT (1) | ATE157007T1 (pt) |
AU (1) | AU647216B2 (pt) |
CA (1) | CA2056967A1 (pt) |
DE (1) | DE69127350D1 (pt) |
HU (1) | HUT61567A (pt) |
IE (1) | IE914248A1 (pt) |
PT (1) | PT99690B (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5561134A (en) * | 1990-09-25 | 1996-10-01 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
JPH06510427A (ja) * | 1991-08-09 | 1994-11-24 | マサチユセツツ・インスチチユート・オブ・テクノロジー | Tau/ニューロフィラメント蛋白質キナーゼpk40及びpk36 |
DK62592D0 (pt) * | 1992-05-14 | 1992-05-14 | Novo Nordisk As | |
DK62692D0 (pt) * | 1992-05-14 | 1992-05-14 | Novo Nordisk As | |
EP0601322A3 (en) * | 1992-10-27 | 1994-10-12 | Nippon Zoki Pharmaceutical Co | Adenosine deaminase inhibitor. |
DK155292D0 (da) * | 1992-12-23 | 1992-12-23 | Novo Nordisk As | Kemiske forbindelser, deres fremstilling og anvendelse |
US5589467A (en) * | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
WO1995030683A1 (en) * | 1994-05-10 | 1995-11-16 | Sandoz Ltd. | Adenosine derivatives |
WO1997033590A1 (en) * | 1996-03-13 | 1997-09-18 | Novo Nordisk A/S | A method of treating disorders related to cytokines in mammals |
WO1997033591A1 (en) * | 1996-03-13 | 1997-09-18 | Novo Nordisk A/S | A method of treating disorders related to cytokines in mammals |
AU4377397A (en) * | 1996-10-14 | 1998-05-11 | Novo Nordisk A/S | Novel therapeutically active adenosine derivatives |
WO1999006059A2 (en) * | 1997-07-30 | 1999-02-11 | Board Of Regents, The University Of Texas System | Methods and compositions relating to no-mediated cytotoxicity |
US5998386A (en) * | 1997-09-19 | 1999-12-07 | Feldman; Arthur M. | Pharmaceutical compositions and method of using same for the treatment of failing myocardial tissue |
US6252061B1 (en) | 1998-03-23 | 2001-06-26 | Reliable Biopharmaceutical, Inc. | Process for the production of 2-halo-6-aminopurine derivatives |
JP3619017B2 (ja) | 1998-06-24 | 2005-02-09 | 日本臓器製薬株式会社 | 新規アラビノシルアデニン誘導体 |
ATE475432T1 (de) | 2000-09-08 | 2010-08-15 | Daiichi Sankyo Co Ltd | Arzneimittel für herzversagen |
EP1258247A1 (en) * | 2001-05-14 | 2002-11-20 | Aventis Pharma Deutschland GmbH | Adenosine analogues for the treatment of insulin resistance syndrome and diabetes |
JP5145563B2 (ja) * | 2005-11-24 | 2013-02-20 | 国立大学法人北海道大学 | 神経変性疾患治療薬 |
BRPI0713902A2 (pt) | 2006-06-27 | 2012-11-27 | Biovitrum Ab | compostos terapêuticos |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2230160A1 (de) * | 1972-06-21 | 1974-01-31 | Merck Patent Gmbh | Adenosinderivat |
AU579412B2 (en) * | 1984-10-26 | 1988-11-24 | Warner-Lambert Company | N` - substituted adenosines |
WO1988003147A1 (en) * | 1986-10-31 | 1988-05-05 | Warner-Lambert Company | Selected n6-substituted adenosines having selective a2 binding activity |
AU8274187A (en) * | 1986-10-31 | 1988-05-25 | Warner-Lambert Company | Heteroaromatic derivatives of adenosine |
JPH0723394B2 (ja) | 1986-11-27 | 1995-03-15 | 日本臓器製薬株式会社 | 新規アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物 |
US4962194A (en) * | 1987-04-02 | 1990-10-09 | Warner-Lambert Company | Method of preparing 51,N6-disubstituted adenosines from inosines |
GB2226027B (en) * | 1988-12-13 | 1992-05-20 | Sandoz Ltd | Adenosine derivatives,their production and use |
JPH0725785B2 (ja) * | 1989-01-11 | 1995-03-22 | 日本臓器製薬株式会社 | アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物 |
-
1991
- 1991-11-25 HU HU913662A patent/HUT61567A/hu unknown
- 1991-12-04 CA CA002056967A patent/CA2056967A1/en not_active Abandoned
- 1991-12-05 AT AT91810942T patent/ATE157007T1/de not_active IP Right Cessation
- 1991-12-05 EP EP91810942A patent/EP0490818B1/en not_active Expired - Lifetime
- 1991-12-05 AU AU88887/91A patent/AU647216B2/en not_active Ceased
- 1991-12-05 DE DE69127350T patent/DE69127350D1/de not_active Expired - Lifetime
- 1991-12-05 EP EP96120163A patent/EP0774259A1/en not_active Withdrawn
- 1991-12-05 PT PT99690A patent/PT99690B/pt not_active IP Right Cessation
- 1991-12-06 IE IE424891A patent/IE914248A1/en unknown
- 1991-12-06 JP JP3322985A patent/JPH04290895A/ja active Pending
-
1996
- 1996-08-16 JP JP8216309A patent/JPH09110700A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
HUT61567A (en) | 1993-01-28 |
ATE157007T1 (de) | 1997-09-15 |
HU913662D0 (en) | 1992-02-28 |
IE914248A1 (en) | 1992-06-17 |
JPH04290895A (ja) | 1992-10-15 |
AU647216B2 (en) | 1994-03-17 |
JPH09110700A (ja) | 1997-04-28 |
CA2056967A1 (en) | 1992-06-08 |
DE69127350D1 (de) | 1997-09-25 |
AU8888791A (en) | 1992-06-11 |
PT99690B (pt) | 1999-05-31 |
EP0774259A1 (en) | 1997-05-21 |
EP0490818B1 (en) | 1997-08-20 |
EP0490818A1 (en) | 1992-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT99690A (pt) | Metodo para o tratamento de doencas utilizando derivados de 2'-o-alquil-adenosina e para a preparacao de composicoes que os contem e de um hidrato de 6-ciclo- -hexil-2'-ometil-adenosina | |
KR890003369A (ko) | 약제학적 제제 | |
ATE94877T1 (de) | Piperazinylderivate von purinen und deren isostere als hypoglykaemische wirkstoffe. | |
ATE233262T1 (de) | Pcp-rezeptor-liganden und deren verwendung | |
PT1137416E (pt) | Uso de derivados n-alquilo de cadeia longa de desoxinojirimicina para o fabrico de um medicamento para o tratamento de doencas ligadas ao armazenamento de glicolipidos | |
SE8102193L (sv) | Terapeutiskt aktiv organisk forening och dess anvendning | |
BR9910921A (pt) | Composto, processo para preparar o mesmo, formulação farmacêutica, uso de um composto, e, processo para a profilaxia e/ou tratamento de condições clìnicas associadas com a resistência à insulina | |
NO178914C (no) | Fremgangsmåte for fremstilling av et farmasöytisk preparat for behandling av Diabetes mellitus | |
DE69634556D1 (de) | L-Carnitin oder ihre Derivate und Resveratrol oder ihre Derivate zur Vorbeugung und Behandlung von kardiovaskulären Erkrankungen, peripheren Gefässkrankheit, peripheren diabetischen Neuropathie und diese enthaltende pharmazeutische Zusammensetzungen | |
DE3779500D1 (de) | Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen. | |
ATE131173T1 (de) | Fluorierte gallensäure-derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen daraus. | |
ATE16183T1 (de) | Thiazolidin-verbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
ES2128309T3 (es) | Utilizacion de taurina para la fabricacion de un medicamento para estimular actividad de mieloperoxidasa. | |
AR029190A1 (es) | Composiciones que contienen derivados del acido hidroxieicosatetraenoico y uso para la manufactura de un medicamento en el tratamiento de trastornos del ojo seco | |
PT920865E (pt) | Utilizacao de ""norastemizole"" para o tratamento de disturbios alergicos | |
BRPI9913746B8 (pt) | composto da série de piridínio, processo para prepará-lo, uso do mesmo, composição farmacêutica para o tratamento de complicações diabéticas e doenças relacionadas ao envelhecimento, e, métodos para a preparação de uma formulação parenteral | |
DK199789D0 (da) | Anvendelse af et phenylquinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et topisk farmaceutisk praeparat til behandling af hud- og/eller slimepithelsygdomme | |
HK1058190A1 (en) | Novel heterocyclic analogs of diphenylethylene compounds | |
DE69007065D1 (de) | Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten. | |
FI953260A (fi) | Farmaseuttiset koostumukset ja menetelmä niiden valmistamiseksi | |
KR880004810A (ko) | 소화성 궤양 치료제 | |
DK0378146T3 (da) | Polyamin-derivater som antineoplastiske midler | |
PT92189A (pt) | Processo para a preparacao de derivados de difenilacetamidas e de composicoes farmaceuticas que os contem | |
ATE2746T1 (de) | Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
FR2648135B1 (fr) | Derives de phenyl-1-dihydro-1,4 amino-3 oxo-4 pyridazines, leur preparation et leur application en therapeutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1A | Laying open of patent application |
Effective date: 19920612 |
|
FG3A | Patent granted, date of granting |
Effective date: 19990212 |
|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20000831 |